Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2006 Should I Stay or Should I Go? The Physician in Time of Crisis, Commentary 2 John Wadleigh, DO Clinical case examines physicians’ duties and risks during an epidemic. Commentaries address physician’s rights vs patients’ rights. Does the duty to treat always override personal or family concerns? Virtual Mentor. 2006;8(4):212-213. doi: 10.1001/virtualmentor.2006.8.4.ccas3-0604. Medicine and Society Jun 2024 How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections? Jeannie P. Cimiotti, PhD, RN, Kimberly Adams Tufts, ND, WHNP-BC, Lucia D. Wocial, PhD, RN, HEC-C, and Elizabeth Peter, PhD, RN Some patients’ end-of-life care plans still require good antimicrobial management. AMA J Ethics. 2024;26(6):E486-493. doi: 10.1001/amajethics.2024.486. Case and Commentary Jun 2024 When Should Patients at the End of Life Get Antimicrobials? Noah Boton, MD and Jeffrey Larnard, MD Some clinicians might neglect discussing benefits and harms of antimicrobials with their patients during advance care planning processes. AMA J Ethics. 2024;26(6):E456-462. doi: 10.1001/amajethics.2024.456. Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4
Case and Commentary Apr 2006 Should I Stay or Should I Go? The Physician in Time of Crisis, Commentary 2 John Wadleigh, DO Clinical case examines physicians’ duties and risks during an epidemic. Commentaries address physician’s rights vs patients’ rights. Does the duty to treat always override personal or family concerns? Virtual Mentor. 2006;8(4):212-213. doi: 10.1001/virtualmentor.2006.8.4.ccas3-0604.
Medicine and Society Jun 2024 How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections? Jeannie P. Cimiotti, PhD, RN, Kimberly Adams Tufts, ND, WHNP-BC, Lucia D. Wocial, PhD, RN, HEC-C, and Elizabeth Peter, PhD, RN Some patients’ end-of-life care plans still require good antimicrobial management. AMA J Ethics. 2024;26(6):E486-493. doi: 10.1001/amajethics.2024.486.
Case and Commentary Jun 2024 When Should Patients at the End of Life Get Antimicrobials? Noah Boton, MD and Jeffrey Larnard, MD Some clinicians might neglect discussing benefits and harms of antimicrobials with their patients during advance care planning processes. AMA J Ethics. 2024;26(6):E456-462. doi: 10.1001/amajethics.2024.456.
Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289.